Literature DB >> 27264733

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes.

Bernard Pereira, Suet-Feung Chin, Oscar M Rueda, Hans-Kristian Moen Vollan, Elena Provenzano, Helen A Bardwell, Michelle Pugh, Linda Jones, Roslin Russell, Stephen-John Sammut, Dana W Y Tsui, Bin Liu, Sarah-Jane Dawson, Jean Abraham, Helen Northen, John F Peden, Abhik Mukherjee, Gulisa Turashvili, Andrew R Green, Steve McKinney, Arusha Oloumi, Sohrab Shah, Nitzan Rosenfeld, Leigh Murphy, David R Bentley, Ian O Ellis, Arnie Purushotham, Sarah E Pinder, Anne-Lise Børresen-Dale, Helena M Earl, Paul D Pharoah, Mark T Ross, Samuel Aparicio, Carlos Caldas.   

Abstract

Entities:  

Year:  2016        PMID： 27264733      PMCID： PMC4897742          DOI： 10.1038/ncomms11908

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
The original version of this Article contained an error in the spelling of ‘refine' in the title of the paper. This has now been corrected in both the PDF and HTML.
  46 in total

Review 1.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

2.  Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

Authors:  Svasti Haricharan; Nindo Punturi; Purba Singh; Kimberly R Holloway; Meenakshi Anurag; Jacob Schmelz; Cheryl Schmidt; Jonathan T Lei; Vera Suman; Kelly Hunt; John A Olson; Jeremy Hoog; Shunqiang Li; Shixia Huang; Dean P Edwards; Shyam M Kavuri; Matthew N Bainbridge; Cynthia X Ma; Matthew J Ellis
Journal:  Cancer Discov       Date:  2017-08-11       Impact factor: 39.397

3.  MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.

Authors:  Sisheng Liu; Jinpeng Liu; Yanqi Xie; Tingting Zhai; Eugene W Hinderer; Arnold J Stromberg; Nathan L Vanderford; Jill M Kolesar; Hunter N B Moseley; Li Chen; Chunming Liu; Chi Wang
Journal:  Bioinformatics       Date:  2021-06-09       Impact factor: 6.937

4.  GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.

Authors:  Lisette M Cornelissen; Roebi de Bruijn; Linda Henneman; Yongsoo Kim; Wilbert Zwart; Jos Jonkers
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-19       Impact factor: 2.673

5.  Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.

Authors:  Marion Lavigne; Emmanuelle Menet; Jean-Christophe Tille; Marick Lae; Laetitia Fuhrmann; Claire Bonneau; Gabrielle Deniziaut; Samia Melaabi; Charlotte C K Ng; Caterina Marchiò; Roman Rouzier; Ivan Bièche; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2017-09-08       Impact factor: 7.842

Review 6.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

7.  Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes.

Authors:  I Chae Ye; Elana J Fertig; Josh W DiGiacomo; Michael Considine; Inês Godet; Daniele M Gilkes
Journal:  Mol Cancer Res       Date:  2018-07-23       Impact factor: 5.852

8.  The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.

Authors:  Ben O'Leary; Rosalind J Cutts; Yuan Liu; Sarah Hrebien; Xin Huang; Kerry Fenwick; Fabrice André; Sibylle Loibl; Sherene Loi; Isaac Garcia-Murillas; Massimo Cristofanilli; Cynthia Huang Bartlett; Nicholas C Turner
Journal:  Cancer Discov       Date:  2018-09-11       Impact factor: 39.397

9.  Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.

Authors:  Hitomi Motomura; Ayaka Ozaki; Shoma Tamori; Chotaro Onaga; Yuka Nozaki; Yuko Waki; Ryoko Takasawa; Kazumi Yoshizawa; Yasunari Mano; Tsugumichi Sato; Kazunori Sasaki; Hitoshi Ishiguro; Yohei Miyagi; Yoji Nagashima; Kouji Yamamoto; Keiko Sato; Takehisa Hanawa; Sei-Ichi Tanuma; Shigeo Ohno; Kazunori Akimoto
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967

10.  Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.

Authors:  Rui Luo; Weelic Chong; Qiang Wei; Zhenchao Zhang; Chun Wang; Zhong Ye; Maysa M Abu-Khalaf; Daniel P Silver; Robert T Stapp; Wei Jiang; Ronald E Myers; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  NPJ Breast Cancer       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.